Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGYG.L Regulatory News (GYG)

  • There is currently no data for GYG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Harwood Capital LLP

21 Apr 2021 07:00

RNS Number : 0891W
Harwood Capital LLP
21 April 2021
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Harwood Capital LLP on behalf of funds and private clients managed, advised or controlled by Harwood Capital LLP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

The Harwood Funds (as defined below)

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

GYG plc ("GYG")

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

20 April 2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary Shares of £0.002 each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

 

TOTAL:

Nil

Nil

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None.

Details, including nature of the rights concerned and relevant percentages:

None.

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

Oryx International Growth Fund Limited ("Oryx") and Harwood Capital Nominees Limited (together, the "Harwood Funds") are managed, advised or controlled by Harwood Capital LLP or its group entities and are therefore deemed to be acting in concert with Harwood Capital LLP.

 

The existing beneficial interests of the Harwood Funds in the ordinary shares of £0.002 each in GYG ("Ordinary Shares") are as follows:

 

Shareholder

Ordinary Shares held

Number

%

Harwood Capital Nominees Limited*

110,000

0.23%

Oryx

9,500,000

20.38%

Total

9,610,000

20.61%

 

Note:

* - controlled by Harwood Capital LLP

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

21 April 2021

Contact name:

Harry Mills

Telephone number:

+44 (0) 20 7640 3288

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEESEDFMSEFSELL
Date   Source Headline
20th Nov 200711:55 amRNSEPT Disclosure
20th Nov 200711:42 amRNSRule 8.3- (Gyrus Group PLC)
20th Nov 200711:42 amRNSRule 8.3- Gyrus Group PLC
20th Nov 200711:25 amBUSRule 8.3 - Gyrus Group Plc
20th Nov 200710:53 amRNSEPT Disclosure
19th Nov 20073:57 pmRNSHolding(s) in Company
19th Nov 20077:02 amRNSAcquisition by Olympus
16th Nov 20077:01 amRNSStatement re Patent Dispute
9th Nov 20075:47 pmRNSHolding(s) in Company
7th Nov 200712:51 pmRNSHolding(s) in Company
31st Oct 20072:07 pmRNSTotal Voting Rights
29th Oct 200711:00 amBUSGyrus ACMI Introduces the World's First Endoscope Protection System (EPS) Designed to Prevent Accidental Laser Damage
25th Oct 20074:24 pmBUSGyrus ACMI to Market Revolutionary ''Bagless'' OPTION-v(TM) Valved Urinary Catheters
4th Oct 20079:22 amRNSHolding(s) in Company
1st Oct 20075:56 pmRNSTotal Voting Rights
24th Sep 20075:03 pmRNSHolding(s) in Company
17th Sep 20072:13 pmRNSDirector/PDMR Shareholding
17th Sep 20077:01 amRNSInterim Results
3rd Sep 20078:33 amRNSTotal Voting Rights
17th Aug 20079:13 amRNSDirector/PDMR Shareholding
31st Jul 20075:45 pmRNSTotal Voting Rights
30th Jul 20074:58 pmRNSFurther re Additional Listing
27th Jul 20073:34 pmRNSAdditional Listing
17th Jul 20077:00 amRNSTrading Statement
8th Jun 20073:30 pmRNSDirector/PDMR Shareholding
8th Jun 20073:24 pmRNSDirector/PDMR Shareholding
8th Jun 20073:20 pmRNSBlocklisting Interim Review
6th Jun 20077:01 amRNSDirector/PDMR Shareholding
4th Jun 20075:21 pmRNSDirector/PDMR Shareholding
1st Jun 20077:01 amRNSAppointment of CEO
31st May 20072:11 pmRNSTotal Voting Rights
24th May 200710:12 amRNSHolding(s) in Company
11th May 20074:18 pmRNSDirector/PDMR Shareholding
2nd May 20072:41 pmRNSResult of AGM
2nd May 20072:33 pmRNSTotal Voting Rights
30th Apr 20074:49 pmRNSResult of AGM
23rd Apr 20073:14 pmRNSHolding(s) in Company
20th Apr 20074:07 pmRNSAnnual Information Update
5th Apr 20072:48 pmRNSAnnual Report and Accounts
30th Mar 20073:26 pmRNSTotal Voting Rights
27th Mar 20076:23 pmRNSDirector/PDMR Shareholding
27th Mar 20076:17 pmRNSDirector/PDMR Shareholding
27th Mar 20076:01 pmRNSHolding(s) in Company
26th Mar 200711:50 amRNSDirector/PDMR Shareholding
19th Mar 20072:37 pmRNSHolding(s) in Company
19th Mar 20072:30 pmRNSHolding(s) in Company
16th Mar 20077:01 amRNSFinal Results
13th Mar 20074:03 pmRNSHolding(s) in Company
13th Mar 20073:56 pmRNSHolding(s) in Company
28th Feb 200712:33 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.